Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,500 shares at $246.02 ($374K) on 2020-12-29, disclosed to the SEC on 2020-12-30.
Open-market sale of $374k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $244.90 | 200 | $49K | 13.1% |
| 2 | $246.02 | 300 | $74K | 19.8% |
| 3 | $247.98 | 200 | $50K | 13.3% |
| 4 | $249.88 | 200 | $50K | 13.4% |
| 5 | $251.58 | 300 | $75K | 20.2% |
| 6 | $252.86 | 300 |
| $76K |
| 20.3% |
| Total | $249.13 avg | 1,500 | $374K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |